VEON Ltd. | ||||
Claude Debussylaan 88 | ||||
1082 MD Amsterdam | ||||
The Netherlands | ||||
VIA EDGAR | ||||
T | +31 (0)20 797 72 00 | |||
U.S. Securities and Exchange Commission | F | +31 (0)20 797 72 01 | ||
100 F Street, N.E. | W | www.veon.com | ||
Washington, DC 20549 | ||||
Trade reg. 34374835 | ||||
VAT | 821815568B01 |
April 3, 2017
Re: | Notice of disclosure filed in Exchange Act Annual Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act |
Ladies and Gentlemen:
Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended, notice is hereby provided that VEON Ltd. has made disclosure pursuant to those provisions in its Annual Report on Form20-F for the year ended December 31, 2016, which was filed with the Securities and Exchange Commission on April 3, 2017.
Please do not hesitate to call the undersigned at +31 20 797 7200 if you have further questions.
Respectfully submitted, | ||
VEON Ltd. | ||
By: | /s/ Scott Dresser | |
Scott Dresser | ||
Group General Counsel |